blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3805367

EP3805367 - COMPOSITIONS AND METHODS FOR INDUCING THE ACTIVATION OF IMMATURE MONOCYTIC DENDRITIC CELLS [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  22.10.2021
Database last updated on 14.11.2024
FormerThe application has been published
Status updated on  12.03.2021
Most recent event   Tooltip06.06.2024New entry: Additional fee for renewal fee: payment of fee 
06.06.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
NorthWest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800
Bethesda, MD 20814 / US
[2021/15]
Inventor(s)01 / BOYNTON, Alton L.
P.O. Box 1863
Kingston, Washington 98346-1863 / US
02 / BOSCH, Marnix L.
7814 N.e. 14th Street
Medina, Washington 98039 / US
 [2021/15]
Representative(s)Forresters IP LLP
Skygarden
Erika-Mann-Straße 11
80636 München / DE
[2021/15]
Application number, filing date20196461.608.12.2006
[2021/15]
Priority number, dateUS20050748885P08.12.2005         Original published format: US 748885 P
[2021/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3805367
Date:14.04.2021
Language:EN
[2021/15]
Search report(s)(Supplementary) European search report - dispatched on:EP12.03.2021
ClassificationIPC:C12N5/07, C12N5/00, A61K39/00, A61P31/04, A61P31/12, A61P35/00, A61P37/04, C12N5/0784
[2021/15]
CPC:
C12N5/0639 (EP,KR,US); A61K2239/47 (EP,US); A61K39/4611 (KR);
A61K39/4615 (EP,KR,US); A61K39/4622 (EP,US); A61K39/4644 (KR);
A61K39/464499 (EP,US); A61P31/04 (EP); A61P31/12 (EP);
A61P35/00 (EP,KR); A61P37/04 (EP); C07K14/4748 (KR);
C12N5/0636 (EP,KR,US); A61K2121/00 (KR); A61K2300/00 (KR);
C12N2501/22 (EP,KR,US); C12N2501/23 (EP,US); C12N2501/2304 (KR);
C12N2501/2313 (KR); C12N2501/2315 (KR); C12N2501/24 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2021/47]
Former [2021/15]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR INDUZIERUNG DER AKTIVIERUNG UNREIFER MONOZYTISCHER DENDRITENZELLEN[2021/15]
English:COMPOSITIONS AND METHODS FOR INDUCING THE ACTIVATION OF IMMATURE MONOCYTIC DENDRITIC CELLS[2021/15]
French:COMPOSITIONS ET PROCEDES PERMETTANT D'INDUIRE L'ACTIVATION DE CELLULES DENDRITIQUES MONOCYTIQUES IMMATURES[2021/15]
Examination procedure14.10.2021Amendment by applicant (claims and/or description)
14.10.2021Examination requested  [2021/47]
14.10.2021Date on which the examining division has become responsible
Parent application(s)   TooltipEP06848532.5  / EP1957634
EP16170001.8  / EP3072958
Fees paidRenewal fee
13.01.2021Renewal fee patent year 03
13.01.2021Renewal fee patent year 04
13.01.2021Renewal fee patent year 05
13.01.2021Renewal fee patent year 06
13.01.2021Renewal fee patent year 07
13.01.2021Renewal fee patent year 08
13.01.2021Renewal fee patent year 09
13.01.2021Renewal fee patent year 10
13.01.2021Renewal fee patent year 11
13.01.2021Renewal fee patent year 12
13.01.2021Renewal fee patent year 13
13.01.2021Renewal fee patent year 14
13.01.2021Renewal fee patent year 15
08.06.2022Renewal fee patent year 16
13.06.2023Renewal fee patent year 17
06.06.2024Renewal fee patent year 18
Penalty fee
Additional fee for renewal fee
31.12.202116   M06   Fee paid on   08.06.2022
31.12.202217   M06   Fee paid on   13.06.2023
31.12.202318   M06   Fee paid on   06.06.2024
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2004024900  (FORSCH KREBSKRANKE KINDER [AT], et al);
 [X]WO2004076651  (NORTHWEST BIOTHERAPEUTICS INC [US], et al);
by applicantUS5788963
 US5994126
 WO0047719
 US2002160430
 WO03010292
 WO2004000444
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.